Gregg L Semenza
President bij The Johns Hopkins University School of Medicine
Profiel
Gregg L Semenza is the Director at the Institute For Cell Engineering.
He is also a Professor of Genetic Medicine at The Johns Hopkins University School of Medicine since 1990.
Additionally, he is a Venture Partner at Catalio Capital Management LP and an Advisor at Medical Excellence Capital LLC.
Semenza holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Actieve functies van Gregg L Semenza
Bedrijven | Functie | Begin |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Consultant / Adviseur | - |
The Johns Hopkins University School of Medicine | President | 01-01-1990 |
Institute For Cell Engineering | Directeur/Bestuurslid | - |
Opleiding van Gregg L Semenza
University of Pennsylvania | Doctorate Degree |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
Institute For Cell Engineering |